Generation of lentivirus vectors using recombinant baculoviruses | Gene Therapy
Lentivirus vector system, lentivirus production and transduction | GeneMedi
Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives - Shearer - 2015 - Genes to Cells - Wiley Online Library
Improved third-generation lentiviral packaging with pLKO.1C vectors | BioTechniques
The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells: Molecular Therapy - Methods & Clinical Development
Addgene: Lentiviral Guide
A Third-Generation Lentivirus Vector with a Conditional Packaging System | Journal of Virology
Biomedicines | Free Full-Text | Design and Potential of Non-Integrating Lentiviral Vectors | HTML
Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases | Scientific Reports
Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases - ScienceDirect
Addgene: Lentiviral Guide
Gene Regulatable Lentiviral Vector System | IntechOpen
Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy: Molecular Therapy
A Third-Generation Lentivirus Vector with a Conditional Packaging System | Journal of Virology
Lentiviral Vector Uses and Overview
Lentivirus - Introduction | ABM Inc.
Lentiviral Vector Uses and Overview
Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice | Human Gene Therapy Methods
Development of a Novel Trans-Lentiviral Vector That Affords Predictable Safety: Molecular Therapy
Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectors: Molecular Therapy - Methods & Clinical Development
Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges - ScienceDirect
A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors: Molecular Therapy
